Intravenous interleukin-2 in patients over 65 with metastatic renal carcinoma.

The present study was designed in order to evaluate the response rate and the toxicity of continuous infusion of Interleukin 2 (IL2) in patients over 65 with metastatic renal cell carcinoma. Twenty-five patients, median age 69 (range 65-77), without any prior systemic anticancer therapy received a c...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Négrier, S., Mercatello, A., Bret, M., Thiesse, P., Blay, J. Y., Coronel, B., Merrouche, Y., Oskam, R., Franks, C. R., Clavel, M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 1992
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1977403/
https://ncbi.nlm.nih.gov/pubmed/1586600
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky